Savant Capital’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
99,183
+54,952
| +124% | +$951K | 0.01% | 617 |
|
|
2025
Q1 | $967K | Buy |
44,231
+12,706
| +40% | +$278K | 0.01% | 770 |
|
|
2024
Q4 | $1.01M | Buy |
31,525
+9,407
| +43% | +$300K | 0.01% | 651 |
|
|
2024
Q3 | $638K | Buy |
22,118
+8,520
| +63% | +$246K | 0.01% | 778 |
|
|
2024
Q2 | $522K | Buy |
+13,598
| New | +$522K | 0.01% | 782 |
|